| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 4.23e-06 | 3 | 25 | 2 | GO:0021775 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 4.23e-06 | 3 | 25 | 2 | GO:0021776 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord patterning | 4.23e-06 | 3 | 25 | 2 | GO:0021910 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 2.95e-05 | 7 | 25 | 2 | GO:0060831 | |
| GeneOntologyBiologicalProcess | cell fate specification involved in pattern specification | 3.93e-05 | 8 | 25 | 2 | GO:0060573 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron specification | 3.93e-05 | 8 | 25 | 2 | GO:0021521 | |
| GeneOntologyBiologicalProcess | hindgut morphogenesis | 5.05e-05 | 9 | 25 | 2 | GO:0007442 | |
| GeneOntologyBiologicalProcess | hindgut development | 6.31e-05 | 10 | 25 | 2 | GO:0061525 | |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 6.54e-05 | 65 | 25 | 3 | GO:0060443 | |
| GeneOntologyBiologicalProcess | spinal cord motor neuron cell fate specification | 7.71e-05 | 11 | 25 | 2 | GO:0021520 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 8.46e-05 | 1269 | 25 | 8 | GO:0009887 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 8.90e-05 | 198 | 25 | 4 | GO:0048754 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron fate commitment | 9.24e-05 | 12 | 25 | 2 | GO:0060579 | |
| GeneOntologyBiologicalProcess | cell fate commitment involved in pattern specification | 9.24e-05 | 12 | 25 | 2 | GO:0060581 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron differentiation | 1.27e-04 | 14 | 25 | 2 | GO:0021514 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 1.31e-04 | 421 | 25 | 5 | GO:0060562 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 1.75e-04 | 236 | 25 | 4 | GO:0061138 | |
| GeneOntologyBiologicalProcess | epithelium development | 2.35e-04 | 1469 | 25 | 8 | GO:0060429 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 2.46e-04 | 258 | 25 | 4 | GO:0001763 | |
| GeneOntologyBiologicalProcess | spinal cord dorsal/ventral patterning | 2.64e-04 | 20 | 25 | 2 | GO:0021513 | |
| GeneOntologyBiologicalProcess | dosage compensation by inactivation of X chromosome | 3.21e-04 | 22 | 25 | 2 | GO:0009048 | |
| GeneOntologyBiologicalProcess | spinal cord patterning | 3.21e-04 | 22 | 25 | 2 | GO:0021511 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 3.54e-04 | 284 | 25 | 4 | GO:0009913 | |
| GeneOntologyBiologicalProcess | sex-chromosome dosage compensation | 3.83e-04 | 24 | 25 | 2 | GO:0007549 | |
| GeneOntologyBiologicalProcess | dorsal/ventral neural tube patterning | 4.16e-04 | 25 | 25 | 2 | GO:0021904 | |
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte differentiation | 4.86e-04 | 27 | 25 | 2 | GO:0032331 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 7.73e-04 | 619 | 25 | 5 | GO:0002009 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 7.86e-04 | 351 | 25 | 4 | GO:0048562 | |
| GeneOntologyBiologicalProcess | odontogenesis | 7.86e-04 | 151 | 25 | 3 | GO:0042476 | |
| GeneOntologyBiologicalProcess | embryonic digestive tract development | 8.19e-04 | 35 | 25 | 2 | GO:0048566 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 8.66e-04 | 36 | 25 | 2 | GO:0061037 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 9.15e-04 | 37 | 25 | 2 | GO:0009954 | |
| GeneOntologyBiologicalProcess | mammary gland development | 9.63e-04 | 162 | 25 | 3 | GO:0030879 | |
| GeneOntologyBiologicalProcess | spinal cord motor neuron differentiation | 1.12e-03 | 41 | 25 | 2 | GO:0021522 | |
| GeneOntologyBiologicalProcess | protein localization to chromosome, centromeric region | 1.18e-03 | 42 | 25 | 2 | GO:0071459 | |
| GeneOntologyBiologicalProcess | neuron fate specification | 1.18e-03 | 42 | 25 | 2 | GO:0048665 | |
| GeneOntologyBiologicalProcess | negative regulation of smoothened signaling pathway | 1.18e-03 | 42 | 25 | 2 | GO:0045879 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.26e-03 | 178 | 25 | 3 | GO:0022612 | |
| GeneOntologyBiologicalProcess | neural tube patterning | 1.35e-03 | 45 | 25 | 2 | GO:0021532 | |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 1.35e-03 | 45 | 25 | 2 | GO:0060603 | |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 1.54e-03 | 48 | 25 | 2 | GO:0021696 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly checkpoint signaling | 1.73e-03 | 51 | 25 | 2 | GO:0007094 | |
| GeneOntologyBiologicalProcess | spindle assembly checkpoint signaling | 1.73e-03 | 51 | 25 | 2 | GO:0071173 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 1.82e-03 | 750 | 25 | 5 | GO:0048729 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid separation | 1.87e-03 | 53 | 25 | 2 | GO:2000816 | |
| GeneOntologyBiologicalProcess | mitotic spindle checkpoint signaling | 1.87e-03 | 53 | 25 | 2 | GO:0071174 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic metaphase/anaphase transition | 1.87e-03 | 53 | 25 | 2 | GO:0045841 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid segregation | 1.87e-03 | 53 | 25 | 2 | GO:0033048 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid segregation | 1.87e-03 | 53 | 25 | 2 | GO:0033046 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome separation | 2.01e-03 | 55 | 25 | 2 | GO:1905819 | |
| GeneOntologyBiologicalProcess | negative regulation of metaphase/anaphase transition of cell cycle | 2.01e-03 | 55 | 25 | 2 | GO:1902100 | |
| GeneOntologyBiologicalProcess | ventricular septum morphogenesis | 2.09e-03 | 56 | 25 | 2 | GO:0060412 | |
| GeneOntologyBiologicalProcess | epidermis development | 2.15e-03 | 461 | 25 | 4 | GO:0008544 | |
| GeneOntologyBiologicalProcess | spindle checkpoint signaling | 2.16e-03 | 57 | 25 | 2 | GO:0031577 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome segregation | 2.16e-03 | 57 | 25 | 2 | GO:0051985 | |
| GeneOntologyBiologicalProcess | ventral spinal cord development | 2.16e-03 | 57 | 25 | 2 | GO:0021517 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule cytoskeleton | 2.31e-03 | 59 | 25 | 2 | GO:0072698 | |
| GeneOntologyBiologicalProcess | regulation of chondrocyte differentiation | 2.31e-03 | 59 | 25 | 2 | GO:0032330 | |
| GeneOntologyBiologicalProcess | digestive tract morphogenesis | 2.31e-03 | 59 | 25 | 2 | GO:0048546 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 2.39e-03 | 60 | 25 | 2 | GO:0021587 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 2.39e-03 | 60 | 25 | 2 | GO:0033047 | |
| GeneOntologyBiologicalProcess | cell differentiation in spinal cord | 2.63e-03 | 63 | 25 | 2 | GO:0021515 | |
| GeneOntologyBiologicalProcess | protein localization to cytoskeleton | 2.63e-03 | 63 | 25 | 2 | GO:0044380 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 2.72e-03 | 64 | 25 | 2 | GO:0045839 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 2.72e-03 | 64 | 25 | 2 | GO:0010965 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 2.72e-03 | 64 | 25 | 2 | GO:0021575 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 2.97e-03 | 67 | 25 | 2 | GO:0051306 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 3.33e-03 | 71 | 25 | 2 | GO:0021695 | |
| GeneOntologyBiologicalProcess | inner ear development | 3.44e-03 | 253 | 25 | 3 | GO:0048839 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 3.52e-03 | 73 | 25 | 2 | GO:0051784 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 3.61e-03 | 74 | 25 | 2 | GO:0042733 | |
| GeneOntologyBiologicalProcess | animal organ formation | 4.00e-03 | 78 | 25 | 2 | GO:0048645 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 4.10e-03 | 79 | 25 | 2 | GO:1905818 | |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 4.31e-03 | 81 | 25 | 2 | GO:0061035 | |
| GeneOntologyCellularComponent | GLI-SUFU complex | 8.23e-06 | 4 | 25 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | ciliary tip | 1.50e-03 | 48 | 25 | 2 | GO:0097542 | |
| GeneOntologyCellularComponent | ciliary base | 2.03e-03 | 56 | 25 | 2 | GO:0097546 | |
| GeneOntologyCellularComponent | cornified envelope | 3.07e-03 | 69 | 25 | 2 | GO:0001533 | |
| GeneOntologyCellularComponent | transcription repressor complex | 4.83e-03 | 87 | 25 | 2 | GO:0017053 | |
| MousePheno | enlarged tectum | 2.59e-06 | 2 | 23 | 2 | MP:0009048 | |
| MousePheno | abnormal cerebellum development | 1.67e-05 | 96 | 23 | 4 | MP:0000854 | |
| MousePheno | abnormal right lung accessory lobe morphology | 2.58e-05 | 5 | 23 | 2 | MP:0009571 | |
| MousePheno | abnormal cerebellum external granule cell layer morphology | 8.16e-05 | 52 | 23 | 3 | MP:0000872 | |
| MousePheno | abnormal hindbrain morphology | 1.03e-04 | 485 | 23 | 6 | MP:0000841 | |
| MousePheno | abnormal cerebellar foliation | 1.13e-04 | 58 | 23 | 3 | MP:0000857 | |
| MousePheno | abnormal hindbrain development | 1.36e-04 | 164 | 23 | 4 | MP:0006108 | |
| MousePheno | abnormal pineal gland morphology | 1.41e-04 | 11 | 23 | 2 | MP:0000632 | |
| MousePheno | abnormal cerebellum lobule morphology | 1.90e-04 | 69 | 23 | 3 | MP:0009964 | |
| MousePheno | increased hemolymphoid system tumor incidence | 2.44e-04 | 191 | 23 | 4 | MP:0010296 | |
| MousePheno | increased bone volume | 2.63e-04 | 77 | 23 | 3 | MP:0010875 | |
| MousePheno | increased classified tumor incidence | 3.29e-04 | 381 | 23 | 5 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 3.41e-04 | 384 | 23 | 5 | MP:0020188 | |
| MousePheno | abnormal cerebellum morphology | 3.62e-04 | 389 | 23 | 5 | MP:0000849 | |
| MousePheno | abnormal bone ossification | 3.88e-04 | 395 | 23 | 5 | MP:0008271 | |
| MousePheno | bowed radius | 3.90e-04 | 18 | 23 | 2 | MP:0004374 | |
| MousePheno | abnormal epithalamus morphology | 4.35e-04 | 19 | 23 | 2 | MP:0000840 | |
| MousePheno | hearing/vestibular/ear phenotype | 4.56e-04 | 905 | 23 | 7 | MP:0005377 | |
| MousePheno | reduced cerebellar foliation | 4.83e-04 | 20 | 23 | 2 | MP:0009719 | |
| MousePheno | abnormal inferior colliculus morphology | 4.83e-04 | 20 | 23 | 2 | MP:0000776 | |
| MousePheno | short fibula | 4.83e-04 | 20 | 23 | 2 | MP:0002765 | |
| MousePheno | abnormal metencephalon morphology | 5.14e-04 | 420 | 23 | 5 | MP:0000847 | |
| MousePheno | abnormal superior colliculus morphology | 5.34e-04 | 21 | 23 | 2 | MP:0000904 | |
| MousePheno | decreased lung weight | 6.42e-04 | 23 | 23 | 2 | MP:0005631 | |
| MousePheno | increased total retina thickness | 6.42e-04 | 23 | 23 | 2 | MP:0011964 | |
| MousePheno | abnormal thoracic cage morphology | 8.00e-04 | 463 | 23 | 5 | MP:0004624 | |
| MousePheno | abnormal maternal behavior | 8.52e-04 | 115 | 23 | 3 | MP:0008779 | |
| MousePheno | abnormal palatine bone horizontal plate morphology | 9.54e-04 | 28 | 23 | 2 | MP:0004537 | |
| MousePheno | short sternum | 1.02e-03 | 29 | 23 | 2 | MP:0004321 | |
| MousePheno | abnormal secretory circumventricular organ morphology | 1.02e-03 | 29 | 23 | 2 | MP:0013563 | |
| MousePheno | abnormal optic stalk morphology | 1.10e-03 | 30 | 23 | 2 | MP:0004268 | |
| MousePheno | abnormal circumventricular organ morphology | 1.17e-03 | 31 | 23 | 2 | MP:0013562 | |
| MousePheno | polydactyly | 1.19e-03 | 129 | 23 | 3 | MP:0000562 | |
| MousePheno | increased bone ossification | 1.25e-03 | 32 | 23 | 2 | MP:0020039 | |
| MousePheno | abnormal coat appearance | 1.27e-03 | 774 | 23 | 6 | MP:0001510 | |
| MousePheno | abnormal lung lobe morphology | 1.33e-03 | 33 | 23 | 2 | MP:0010975 | |
| MousePheno | abnormal cerebellar cortex morphology | 1.33e-03 | 300 | 23 | 4 | MP:0004097 | |
| MousePheno | increased tumor incidence | 1.47e-03 | 530 | 23 | 5 | MP:0002020 | |
| MousePheno | abnormal tectum morphology | 1.49e-03 | 35 | 23 | 2 | MP:0006104 | |
| MousePheno | abnormal midbrain roof plate morphology | 1.49e-03 | 35 | 23 | 2 | MP:0006103 | |
| MousePheno | abnormal corpora quadrigemina morphology | 1.49e-03 | 35 | 23 | 2 | MP:0000899 | |
| MousePheno | decreased bone resorption | 1.58e-03 | 36 | 23 | 2 | MP:0004993 | |
| MousePheno | abnormal maxilla morphology | 1.63e-03 | 144 | 23 | 3 | MP:0000455 | |
| MousePheno | abnormal tooth morphology | 1.65e-03 | 318 | 23 | 4 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 1.67e-03 | 319 | 23 | 4 | MP:0030254 | |
| MousePheno | increased leukemia incidence | 1.85e-03 | 39 | 23 | 2 | MP:0002026 | |
| MousePheno | increased embryonic tissue cell apoptosis | 1.94e-03 | 153 | 23 | 3 | MP:0013504 | |
| MousePheno | decreased radius size | 1.94e-03 | 40 | 23 | 2 | MP:0030886 | |
| MousePheno | short radius | 1.94e-03 | 40 | 23 | 2 | MP:0004355 | |
| MousePheno | abnormal stratification in cerebral cortex | 2.04e-03 | 41 | 23 | 2 | MP:0000790 | |
| MousePheno | abnormal coat/ hair morphology | 2.10e-03 | 854 | 23 | 6 | MP:0000367 | |
| MousePheno | abnormal auditory brainstem response | 2.12e-03 | 576 | 23 | 5 | MP:0004738 | |
| MousePheno | abnormal optic cup morphology | 2.14e-03 | 42 | 23 | 2 | MP:0004269 | |
| MousePheno | abnormal parental behavior | 2.20e-03 | 160 | 23 | 3 | MP:0002068 | |
| MousePheno | increased trabecular bone thickness | 2.24e-03 | 43 | 23 | 2 | MP:0009347 | |
| MousePheno | increased hematopoietic stem cell number | 2.24e-03 | 43 | 23 | 2 | MP:0004809 | |
| MousePheno | increased lymphoma incidence | 2.36e-03 | 164 | 23 | 3 | MP:0012431 | |
| MousePheno | abnormal hearing electrophysiology | 2.42e-03 | 594 | 23 | 5 | MP:0006335 | |
| MousePheno | decreased tooth number | 2.56e-03 | 46 | 23 | 2 | MP:0030608 | |
| MousePheno | short ulna | 2.56e-03 | 46 | 23 | 2 | MP:0004359 | |
| MousePheno | abnormal palatine bone morphology | 2.56e-03 | 46 | 23 | 2 | MP:0005249 | |
| MousePheno | decreased ulna size | 2.56e-03 | 46 | 23 | 2 | MP:0030900 | |
| MousePheno | abnormal right lung morphology | 2.68e-03 | 47 | 23 | 2 | MP:0009570 | |
| MousePheno | abnormal bone volume | 2.75e-03 | 173 | 23 | 3 | MP:0010874 | |
| MousePheno | short humerus | 2.79e-03 | 48 | 23 | 2 | MP:0004351 | |
| MousePheno | abnormal vertebral arch morphology | 2.79e-03 | 174 | 23 | 3 | MP:0004599 | |
| MousePheno | abnormal vein morphology | 2.89e-03 | 176 | 23 | 3 | MP:0002725 | |
| MousePheno | increased bone trabecula number | 3.02e-03 | 50 | 23 | 2 | MP:0010868 | |
| MousePheno | abnormal embryonic tissue cell apoptosis | 3.08e-03 | 180 | 23 | 3 | MP:0013503 | |
| MousePheno | abnormal bone mineralization | 3.12e-03 | 181 | 23 | 3 | MP:0002896 | |
| MousePheno | abnormal fibula morphology | 3.14e-03 | 51 | 23 | 2 | MP:0002187 | |
| MousePheno | abnormal palate bone morphology | 3.14e-03 | 51 | 23 | 2 | MP:0009891 | |
| MousePheno | abnormal skeleton physiology | 3.17e-03 | 632 | 23 | 5 | MP:0001533 | |
| MousePheno | abnormal tumor incidence | 3.24e-03 | 635 | 23 | 5 | MP:0002019 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.25e-05 | 31 | 21 | 3 | M39522 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 4.42e-05 | 7 | 21 | 2 | M27501 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC | 9.44e-05 | 10 | 21 | 2 | M47886 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 1.90e-04 | 14 | 21 | 2 | M47414 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 2.19e-04 | 15 | 21 | 2 | MM1498 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP47 | 2.50e-04 | 16 | 21 | 2 | M39675 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 2.50e-04 | 16 | 21 | 2 | M11792 | |
| Pathway | WP_HEDGEHOG_SIGNALING_PATHWAY | 4.80e-04 | 22 | 21 | 2 | MM15924 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 6.98e-04 | 119 | 21 | 3 | M27785 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 8.38e-04 | 29 | 21 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 8.38e-04 | 29 | 21 | 2 | M47377 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 9.58e-04 | 31 | 21 | 2 | M27805 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 1.84e-03 | 43 | 21 | 2 | M39706 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 2.29e-03 | 48 | 21 | 2 | M219 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 2.99e-03 | 55 | 21 | 2 | M17807 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 3.10e-03 | 56 | 21 | 2 | M1053 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 3.55e-03 | 60 | 21 | 2 | M40048 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 10693670 | ||
| Pubmed | The cohesin release factor Wapl interacts with Bub3 to govern SAC activity in female meiosis I. | 4.96e-07 | 2 | 25 | 2 | 32284991 | |
| Pubmed | Adult Gli2+/-;Gli3Δ699/+ Male and Female Mice Display a Spectrum of Genital Malformation. | 4.96e-07 | 2 | 25 | 2 | 27814383 | |
| Pubmed | Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. | 4.96e-07 | 2 | 25 | 2 | 29967343 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 20154143 | ||
| Pubmed | Mouse oocytes depend on BubR1 for proper chromosome segregation but not for prophase I arrest. | 4.96e-07 | 2 | 25 | 2 | 25897860 | |
| Pubmed | Normal exon copy number of the GLI2 and GLI3 genes in patients with esophageal atresia. | 4.96e-07 | 2 | 25 | 2 | 23442119 | |
| Pubmed | Phosphorylation sites in BubR1 that regulate kinetochore attachment, tension, and mitotic exit. | 4.96e-07 | 2 | 25 | 2 | 19015317 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17283082 | ||
| Pubmed | A study on etiology of incontinence in double knockout mouse model. | 4.96e-07 | 2 | 25 | 2 | 36272934 | |
| Pubmed | 1.18e-06 | 29 | 25 | 3 | 26959361 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 19955409 | ||
| Pubmed | Murine models of VACTERL syndrome: Role of sonic hedgehog signaling pathway. | 1.49e-06 | 3 | 25 | 2 | 11172440 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 26010061 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 8387379 | ||
| Pubmed | Positive regulation of Hedgehog signaling via phosphorylation of GLI2/GLI3 by DYRK2 kinase. | 1.49e-06 | 3 | 25 | 2 | 38968120 | |
| Pubmed | Sonic hedgehog through Gli2 and Gli3 is required for the proper development of placental labyrinth. | 1.49e-06 | 3 | 25 | 2 | 25695606 | |
| Pubmed | Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. | 1.49e-06 | 3 | 25 | 2 | 16571352 | |
| Pubmed | Gli family members are differentially expressed during the mitotic phase of spermatogenesis. | 1.49e-06 | 3 | 25 | 2 | 9178901 | |
| Pubmed | Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. | 1.49e-06 | 3 | 25 | 2 | 8378770 | |
| Pubmed | Different expression patterns of Gli1-3 in mouse embryonic maxillofacial development. | 1.49e-06 | 3 | 25 | 2 | 22178118 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 28947820 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 9027508 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 22281533 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 24952464 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 9006072 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 27793025 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 29429990 | ||
| Pubmed | Expression profile of Gli family members and Shh in normal and mutant mouse limb development. | 2.97e-06 | 4 | 25 | 2 | 9438426 | |
| Pubmed | Anorectal malformations caused by defects in sonic hedgehog signaling. | 2.97e-06 | 4 | 25 | 2 | 11485934 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 8150204 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 20956384 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 10531011 | ||
| Pubmed | SUMOylation by Pias1 regulates the activity of the Hedgehog dependent Gli transcription factors. | 4.95e-06 | 5 | 25 | 2 | 20711444 | |
| Pubmed | Functional compensation in Hedgehog signaling during mouse prostate development. | 4.95e-06 | 5 | 25 | 2 | 16707121 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 19996099 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 9118802 | ||
| Pubmed | Evidence for the involvement of the Gli gene family in embryonic mouse lung development. | 4.95e-06 | 5 | 25 | 2 | 9268579 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 17328886 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 16611981 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 15315762 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 10564661 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 24218555 | ||
| Pubmed | Gli regulation by the opposing activities of fused and suppressor of fused. | 4.95e-06 | 5 | 25 | 2 | 10806483 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 26282181 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 17210994 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 19593328 | ||
| Pubmed | Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. | 4.95e-06 | 5 | 25 | 2 | 9216996 | |
| Pubmed | Deubiquitination of Ci/Gli by Usp7/HAUSP Regulates Hedgehog Signaling. | 4.95e-06 | 5 | 25 | 2 | 26120032 | |
| Pubmed | Expression pattern of Irx1 and Irx2 during mouse digit development. | 4.95e-06 | 5 | 25 | 2 | 11472848 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 15614767 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 21549329 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 19432668 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 33895473 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 14681189 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 24174682 | ||
| Pubmed | Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk. | 7.43e-06 | 6 | 25 | 2 | 17268814 | |
| Pubmed | Molecular analysis of coordinated bladder and urogenital organ formation by Hedgehog signaling. | 7.43e-06 | 6 | 25 | 2 | 17202190 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 16254602 | ||
| Pubmed | Coordinated translocation of mammalian Gli proteins and suppressor of fused to the primary cilium. | 7.43e-06 | 6 | 25 | 2 | 21209912 | |
| Pubmed | Targeted disruption of Sonic Hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. | 7.43e-06 | 6 | 25 | 2 | 19536807 | |
| Pubmed | Molecular embryology of the lung: then, now, and in the future. | 7.43e-06 | 6 | 25 | 2 | 10330024 | |
| Pubmed | A novel gene, GliH1, with homology to the Gli zinc finger domain not required for mouse development. | 7.43e-06 | 6 | 25 | 2 | 12385751 | |
| Pubmed | Phosphorylation of Ci/Gli by Fused Family Kinases Promotes Hedgehog Signaling. | 7.43e-06 | 6 | 25 | 2 | 31279575 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 11472847 | ||
| Pubmed | Physical and functional interactions between Zic and Gli proteins. | 7.43e-06 | 6 | 25 | 2 | 11238441 | |
| Pubmed | Hedgehog regulates Norrie disease protein to drive neural progenitor self-renewal. | 1.04e-05 | 7 | 25 | 2 | 23201751 | |
| Pubmed | BMP7 and SHH regulate Pax2 in mouse retinal astrocytes by relieving TLX repression. | 1.04e-05 | 7 | 25 | 2 | 19505455 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 19049965 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 9152005 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 21653639 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 14568100 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 28799057 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 2850480 | ||
| Pubmed | Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus. | 1.04e-05 | 7 | 25 | 2 | 9731531 | |
| Pubmed | Analysis of the Sonic Hedgehog signaling pathway in normal and abnormal bladder development. | 1.04e-05 | 7 | 25 | 2 | 23308271 | |
| Pubmed | Sonic hedgehog regulates discrete populations of astrocytes in the adult mouse forebrain. | 1.04e-05 | 7 | 25 | 2 | 20943901 | |
| Pubmed | Ski is involved in transcriptional regulation by the repressor and full-length forms of Gli3. | 1.04e-05 | 7 | 25 | 2 | 12435627 | |
| Pubmed | Gli3-mediated repression of Hedgehog targets is required for normal mammary development. | 1.04e-05 | 7 | 25 | 2 | 16914490 | |
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 30301781 | ||
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 22265416 | ||
| Pubmed | Expression of hedgehog signalling components in adult mouse testis. | 1.39e-05 | 8 | 25 | 2 | 16958114 | |
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 9988217 | ||
| Pubmed | Requirement of Smad4 from Ocular Surface Ectoderm for Retinal Development. | 1.39e-05 | 8 | 25 | 2 | 27494603 | |
| Pubmed | The transcription factor Gli3 promotes B cell development in fetal liver through repression of Shh. | 1.39e-05 | 8 | 25 | 2 | 28533268 | |
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 34767969 | ||
| Pubmed | Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. | 1.39e-05 | 8 | 25 | 2 | 10529434 | |
| Pubmed | Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation. | 1.39e-05 | 8 | 25 | 2 | 12221011 | |
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 24151075 | ||
| Pubmed | Gli1 is not required for Pdgfralpha expression during mouse embryonic development. | 1.39e-05 | 8 | 25 | 2 | 15811134 | |
| Pubmed | GLI transcriptional repression is inert prior to Hedgehog pathway activation. | 1.39e-05 | 8 | 25 | 2 | 35145123 | |
| Pubmed | Unique functions of Sonic hedgehog signaling during external genitalia development. | 1.39e-05 | 8 | 25 | 2 | 11684660 | |
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 10631181 | ||
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 27802276 | ||
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 38848388 | ||
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 26261006 | ||
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 23249739 | ||
| Pubmed | Sonic Hedgehog mediator Gli2 regulates bladder mesenchymal patterning. | 1.78e-05 | 9 | 25 | 2 | 18710724 | |
| Pubmed | Context-dependent ciliary regulation of hedgehog pathway repression in tissue morphogenesis. | 1.78e-05 | 9 | 25 | 2 | 37943875 | |
| Pubmed | Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia. | 1.78e-05 | 9 | 25 | 2 | 25083987 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.06e-03 | 718 | 16 | 4 | 28 | |
| Coexpression | GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN | 2.65e-05 | 184 | 25 | 4 | M3281 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 3.47e-05 | 680 | 25 | 6 | MM456 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.38e-06 | 149 | 25 | 4 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-06 | 186 | 25 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 25 | 4 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 25 | 4 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 25 | 4 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 25 | 4 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 4.28e-05 | 122 | 25 | 3 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-05 | 158 | 25 | 3 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-05 | 161 | 25 | 3 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-04 | 169 | 25 | 3 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 169 | 25 | 3 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 171 | 25 | 3 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 171 | 25 | 3 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 171 | 25 | 3 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 173 | 25 | 3 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 173 | 25 | 3 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 177 | 25 | 3 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 177 | 25 | 3 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-04 | 177 | 25 | 3 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-3|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.34e-04 | 179 | 25 | 3 | f36776299e570345e18dc38cdef4cfc90e7ed7c2 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 179 | 25 | 3 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 179 | 25 | 3 | dd94ebe69ade6f51b94058abe066216f0de9feda | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 180 | 25 | 3 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.36e-04 | 180 | 25 | 3 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 181 | 25 | 3 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 1.40e-04 | 182 | 25 | 3 | 6745d464c3ff289726aa8164e9a43f407f8e4380 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 25 | 3 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 185 | 25 | 3 | 110d5f02759c8235b14aea524ea47199696094ea | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 25 | 3 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 188 | 25 | 3 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 188 | 25 | 3 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 188 | 25 | 3 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 188 | 25 | 3 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 188 | 25 | 3 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 188 | 25 | 3 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 188 | 25 | 3 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 189 | 25 | 3 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 189 | 25 | 3 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-04 | 190 | 25 | 3 | 67fa7472ec534179087963177351552cc3c335eb | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-04 | 190 | 25 | 3 | 094efcde2b037ae509298abb8b2b1d52f9c86a45 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.59e-04 | 190 | 25 | 3 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 190 | 25 | 3 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-04 | 191 | 25 | 3 | efe0cb0b6602621f5eda72a723b83b38bf15607f | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-04 | 191 | 25 | 3 | 00676c598f6dae0ff9158d064248f1265432f3e1 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.62e-04 | 191 | 25 | 3 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 193 | 25 | 3 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 193 | 25 | 3 | dd9874898587fe9fd9cf2aebc2e0579dcf06944e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 194 | 25 | 3 | f08a7618a9ccf12e4a7620235ae662a8abc521af | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 194 | 25 | 3 | e5b81a8e52259a54a911c1c2ac932c98c988318d | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 194 | 25 | 3 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 195 | 25 | 3 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 195 | 25 | 3 | 3123e02d2894c83962ba402085b5e6422ebf8c73 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.72e-04 | 195 | 25 | 3 | dabf667875ed48fdce4f803f5ead39c71a6df42b | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-04 | 195 | 25 | 3 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-04 | 196 | 25 | 3 | f37ffb916480281e5905733ac304102dd2e0c05f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 196 | 25 | 3 | 35cc0986dc3fc4b89e960a565b8f9810b1688e09 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 196 | 25 | 3 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-04 | 196 | 25 | 3 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 196 | 25 | 3 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_mature|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-04 | 196 | 25 | 3 | 4b9eb163b9dbbf5eebb160f6554f6f28cb234d31 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 196 | 25 | 3 | 36b4f08fc038dfde6343ff0869e1a027d882adb5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 197 | 25 | 3 | 954d4deaeba50c5b3faf52105c4cde961a682be1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 197 | 25 | 3 | 2a89a724e8c15a5bb167fdad7eed31444d8c3d68 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.77e-04 | 197 | 25 | 3 | 1bb8f9535a9ab6c7a444bcbe346fcc0a13b09bdf | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 197 | 25 | 3 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 197 | 25 | 3 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 197 | 25 | 3 | 8e655db7c6f04d49927a1f0a75178e5955b4af08 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-04 | 198 | 25 | 3 | 50f236ab7ef6f00721f6cd714e3eee183077beeb | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 198 | 25 | 3 | 7b9c7ce5d6b7df8db85943b65da1a2c202a8bb53 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-04 | 198 | 25 | 3 | dc0c6189ff9dd76675f63acf1cbc7dda60e75f3f | |
| ToppCell | proximal-Hematologic-Proliferating_NK/T|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.80e-04 | 198 | 25 | 3 | 6c894fda309ec3d4bb446f63d5dde4e7f8c4fd89 | |
| ToppCell | proximal-3-Hematologic-Proliferating_NK/T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.80e-04 | 198 | 25 | 3 | 2777c5efe84ce3dbbe6175ecc1c987bc816ab74b | |
| ToppCell | proximal-Hematologic-Proliferating_NK/T-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.80e-04 | 198 | 25 | 3 | 2e121899f58a5024e26441bd326aac12c37fe6d1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-04 | 199 | 25 | 3 | 13ff6c26ebcc663ef8e5559ab9be99dab848abe7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 199 | 25 | 3 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.82e-04 | 199 | 25 | 3 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | (2)_B_cell-(24)_B_cell_cycling|(2)_B_cell / shred on Cell_type and subtype | 1.82e-04 | 199 | 25 | 3 | d5a9a8a71c4de8cbcef947943f60838731bc640b | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 1.85e-04 | 200 | 25 | 3 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-04 | 200 | 25 | 3 | 0cf7208eab0dc58fbea35e256c5cb55cdd4a4928 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | b71138729d2a81cc2f30e3bc15853516a525a17f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | 31dd81df9aa754a1e69b905bf9b8ce73ff8175aa | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.85e-04 | 200 | 25 | 3 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-04 | 200 | 25 | 3 | 5e1b38e2aa8901bfb2623249f7b6302e97d56ace | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_Macrophages|Biopsy_IPF / Sample group, Lineage and Cell type | 1.85e-04 | 200 | 25 | 3 | 8abb2c25422717e994468ac02d8260344341467f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | 0bba93f1271dac704dddcdea8cb0f84a7ac6f42a | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia|World / Primary Cells by Cluster | 1.85e-04 | 200 | 25 | 3 | ecbbad00e16041a9e1cd88d8bd7279a1b52c0aa4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | 54174a485a82480726fa06efa6e050ddea77cb3c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Stem_cells-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | 8f3067b52865a0f5488e4df0d5a4fea80135cef5 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 200 | 25 | 3 | cab374b7c56310329951c2ca44a7179ffa895b7d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | cfe017b4a4d604a553d0a3df9659687f38e9a7af | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | c9479452ab8c51139522383f745f02171ebbd7e2 | |
| Computational | Genes in the cancer module 303. | 7.68e-04 | 28 | 16 | 2 | MODULE_303 | |
| Computational | Neighborhood of TTK | 1.49e-03 | 39 | 16 | 2 | GNF2_TTK | |
| Computational | Neighborhood of HMMR | 2.16e-03 | 47 | 16 | 2 | GNF2_HMMR | |
| Computational | Neighborhood of BUB1B | 2.35e-03 | 49 | 16 | 2 | GNF2_BUB1B | |
| Computational | Neighborhood of MCM4 | 2.74e-03 | 53 | 16 | 2 | GNF2_MCM4 | |
| Computational | Genes in the cancer module 8. | 2.90e-03 | 421 | 16 | 4 | MODULE_8 | |
| Computational | Neighborhood of CDC20 | 3.05e-03 | 56 | 16 | 2 | GNF2_CDC20 | |
| Computational | Neighborhood of CCNB2 | 3.16e-03 | 57 | 16 | 2 | GNF2_CCNB2 | |
| Computational | Neighborhood of BUB1B | 4.22e-03 | 66 | 16 | 2 | MORF_BUB1B | |
| Computational | Neighborhood of CCNA2 | 4.47e-03 | 68 | 16 | 2 | GNF2_CCNA2 | |
| Computational | Neighborhood of PCNA | 4.47e-03 | 68 | 16 | 2 | GNF2_PCNA | |
| Computational | Neighborhood of RBBP6 | 4.73e-03 | 70 | 16 | 2 | GNF2_RBBP6 | |
| Drug | NADs | 3.23e-05 | 8 | 25 | 2 | CID000074762 | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 4262_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.73e-05 | 195 | 25 | 4 | 4368_DN | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; PC3; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 4551_UP | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 4258_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Up 200; 9uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 5061_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 5749_UP | |
| Disease | cerebrospinal fluid clusterin measurement | 3.04e-06 | 35 | 24 | 3 | EFO_0007657 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 2.27e-05 | 9 | 24 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | seasonal gut microbiome measurement | 1.02e-04 | 112 | 24 | 3 | EFO_0007753 | |
| Disease | blood nickel measurement | 1.25e-04 | 120 | 24 | 3 | EFO_0007583 | |
| Disease | tea consumption measurement | 1.54e-04 | 129 | 24 | 3 | EFO_0010091 | |
| Disease | alpha-linolenic acid measurement | 1.88e-04 | 25 | 24 | 2 | EFO_0007759 | |
| Disease | blood manganese measurement | 2.20e-04 | 27 | 24 | 2 | EFO_0007581 | |
| Disease | cholesteryl ester 22:6 measurement | 3.10e-04 | 32 | 24 | 2 | EFO_0010350 | |
| Disease | FEV/FEC ratio | 3.62e-04 | 1228 | 24 | 6 | EFO_0004713 | |
| Disease | emphysema | 3.71e-04 | 35 | 24 | 2 | EFO_0000464 | |
| Disease | optic disc area measurement | 6.14e-04 | 45 | 24 | 2 | EFO_0006937 | |
| Disease | Gastrointestinal Stromal Sarcoma | 6.70e-04 | 47 | 24 | 2 | C3179349 | |
| Disease | Gastrointestinal Stromal Tumors | 7.58e-04 | 50 | 24 | 2 | C0238198 | |
| Disease | health literacy measurement | 8.52e-04 | 53 | 24 | 2 | EFO_0010104 | |
| Disease | serum selenium measurement | 8.52e-04 | 53 | 24 | 2 | EFO_0005266 | |
| Disease | pentachlorophenol measurement | 1.61e-03 | 73 | 24 | 2 | EFO_0022071 | |
| Disease | parathion measurement | 1.61e-03 | 73 | 24 | 2 | EFO_0022070 | |
| Disease | potassium chromate measurement | 1.61e-03 | 73 | 24 | 2 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 1.61e-03 | 73 | 24 | 2 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 1.61e-03 | 73 | 24 | 2 | EFO_0022067 | |
| Disease | methoxychlor measurement | 1.61e-03 | 73 | 24 | 2 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 1.61e-03 | 73 | 24 | 2 | EFO_0022053 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HSSGFSGSSASVAST | 681 | O60566 | |
| SSSHYHGTSSGSVAA | 3476 | Q96PZ7 | |
| SSYSGSSSSGSSISS | 66 | Q15517 | |
| HTTFSSTSFGGSSSG | 161 | Q8NHS0 | |
| GGSSSSRLHSYSSPS | 116 | Q96T37 | |
| HSSSGEKSASYSSGH | 336 | P35414 | |
| SSSSASGSYGHLSAS | 326 | P10071 | |
| TGGSDYSHLSSTSSE | 21 | Q86V42 | |
| AGSSDTSHTSKYFGS | 1091 | O15055 | |
| ESSSGQSSSYSQHGS | 1171 | Q86YZ3 | |
| ESSSGQSSSYSQHGS | 1641 | Q86YZ3 | |
| ESSSGQSSSYSQHGS | 2111 | Q86YZ3 | |
| ESSSGQSSSYSQHGS | 2581 | Q86YZ3 | |
| SSAASGSYGHLSAGA | 266 | P10070 | |
| SRHSADSHGSSYTSG | 386 | Q8N878 | |
| SSDASGSYSSTMNGH | 61 | P62508 | |
| DSSPTSSTDGHSSYG | 141 | Q00587 | |
| SDSGIATGSHSSYSS | 336 | Q18PE1 | |
| GNCSSSSSSSSDGYL | 106 | Q8NFT8 | |
| TSGYFSHSASNATLS | 1596 | Q9H1H9 | |
| SSGSSHSPSLSSHYS | 256 | A6NNA2 | |
| SHGSSESSLSSTSYS | 1286 | Q9C0A6 | |
| SYSDTGSSTGSHGTS | 521 | Q9P202 | |
| SSYGSHSTDSLMGSS | 386 | O94864 | |
| SYSASSSSSAAAAAG | 51 | Q15022 | |
| LLSSGLYSSGSHSSS | 306 | Q5T1R4 | |
| YDSESSSSGLGHSSD | 171 | Q9Y5X0 | |
| YSGGESHNSSSSKTF | 836 | P33981 |